Breast cancer in Sub-Saharan Africa: Opportunities for prevention

Breast Cancer Research and Treatment

Volumn 144, Issue 3, 2014, Pages 467-478

  Brinton, Louise A ^a   Figueroa, Jonine D ^a   Awuah, Baffour ^b   Yarney, Joel ^c   Wiafe, Seth ^d   Wood, Shannon N ^a   Ansong, Daniel ^b   Nyarko, Kofi ^c   Wiafe Addai, Beatrice ^e   Clegg Lamptey, Joe Nat ^c  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Komfo Anoyke Teaching Hospital   (Ghana)

^c KORLE BU TEACHING HOSPITAL   (Ghana)

^d LOMA LINDA UNIVERSITY   (United States)

^e Peace and Love Hospital   (Ghana)

Author keywords

Breast cancer; Etiology; Incidence; Mortality; Prevention; Sub Saharan africa

Indexed keywords

HORMONE RECEPTOR;

AFRICA SOUTH OF THE SAHARA; BREAST CANCER; CANCER CLASSIFICATION; CANCER INCIDENCE; CANCER MORTALITY; CANCER PREVENTION; CANCER PROGNOSIS; CANCER RISK; ENVIRONMENTAL FACTOR; GEOGRAPHIC DISTRIBUTION; HEALTH CARE ACCESS; HELP SEEKING BEHAVIOR; HEREDITY; HUMAN; LIFESTYLE; PATIENT EDUCATION; PHENOTYPE; PREMENOPAUSE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; TRIPLE NEGATIVE BREAST CANCER;

AFRICA SOUTH OF THE SAHARA; BREAST NEOPLASMS; FEMALE; HEALTH SERVICES ACCESSIBILITY; HUMANS; INCIDENCE; RISK FACTORS;

EID: 84899476777     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-014-2868-z     Document Type: Review

References (84)

1. Akarolo-Anthony SN, Ogundiran TO, Adebamowo CA (2010) Emerging breast cancer epidemic: evidence from Africa. Breast Cancer Res 12(Suppl 4):S8
2. Sylla BS, Wild CP (2012) A million Africans a year dying from cancer by 2030: what can cancer research and control offer to the continent? Int J Cancer 130:245-250
3. Jemal A, Bray F, Forman D et al (2012) Cancer burden in Africa and opportunities for prevention. Cancer 118:4372-4384
4. Parkin DM, Nambooze S, Wabwire-Mangen F, Wabinga HR (2010) Changing cancer incidence in Kampala, Uganda, 1991-2006. Int J Cancer 126:1187-1195
5. Soerjomataram I, Lortet-Tieulent J, Parkin DM et al (2012) Global burden of cancer in 2008: a systematic analysis of disability-adjusted life-years in 12 world regions. Lancet 380:1840-1850
6. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127:2893-2917
7. Ferlay J, Soerjomataram I, Ervik M et al (2013) GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. International Agency for Research on Cancer, Lyon
8. Parkin DM, Sitas F, Chirenje M, Stein L, Abratt R, Wabinga H (2008) Cancer in Indigenous Africans - burden, distribution, and trends. Lancet Oncol 9:683-692 (Pubitemid 351878054)
9. Forman D, Bray F, Brewster DH et al (2013) Cancer incidence in five continents (electronic version). IARC, Lyon
10. Chokunonga E, Borok MZ, Chirenje ZM, Nyakabau AM, Parkin DM (2013) Trends in the incidence of cancer in the black population of Harare, Zimbabwe 1991-2010. Int J Cancer 133:721-729
11. Sighoko D, Kamate B, Traore C et al (2013) Breast cancer in pre-menopausal women in West Africa: analysis of temporal trends and evaluation of risk factors associated with reproductive life. Breast 22:828-835
12. Brinton LA, Sherman ME, Carreon JD, Anderson WF (2008) Recent trends in breast cancer among younger women in the United States. J Natl Cancer Inst 100:1643-1648
13. Parkin DM, Vizcaino AP, Skinner ME, Ndhlovu A (1994) Cancer patterns and risk factors in the African population of southwestern Zimbabwe, 1963-1977. Cancer Epidemiol Biomarkers Prev 3:537-547 (Pubitemid 24314441)
14. Huo D, Adebamowo CA, Ogundiran TO et al (2008) Parity and breastfeeding are protective against breast cancer in Nigerian women. Br J Cancer 98:992-996 (Pubitemid 351341620)
15. Palmer JR, Wise LA, Horton NJ, Adams-Campbell LL, Rosenberg L (2003) Dual effect of parity on breast cancer risk in African-American women. J Natl Cancer Inst 95:478-483 (Pubitemid 36432422)
16. Lambe M, Hsieh C, Trichopoulos D, Ekbom A, Pavia M, Adami HO (1994) Transient increase in the risk of breast cancer after giving birth. N Engl J Med 331:5-9 (Pubitemid 24195593)
17. Okobia M, Bunker C, Zmuda J et al (2006) Case-control study of risk factors for breast cancer in Nigerian women. Int J Cancer 119:2179-2185 (Pubitemid 44423678)
18. Jordan I, Hebestreit A, Swai B, Krawinkel MB (2010). Breast cancer risk among women with long-standing lactation and reproductive parameters at low risk level: a case-control study in Northern Tanzania. Breast Cancer ResTreat. doi 10.1007/s10549-010-1255-7
19. Adebamowo CA, Ogundiran TO, Adenipekun AA et al (2003) Obesity and height in urban Nigerian women with breast cancer. Ann Epidemiol 13:455-461 (Pubitemid 36870815)
20. Coogan PF, Rosenberg L, Shapiro S, Hoffman M (1999) Lactation and breast carcinoma risk in a South African population. Cancer 86:982-989 (Pubitemid 29439852)
21. Baquet CR, Commiskey P (2000) Socioeconomic factors and breast carcinoma in multicultural women. Cancer 88:1256-1264 (Pubitemid 30129741)
22. The World Bank (2013) African development indicators 2012/13 [electronic]. Washington, DC
23. Sitas F, Parkin DM, Chirenje M, Stein L, Abratt R, Wabinga\ H (2008) Cancer in Indigenous Africans - causes and control. Lancet Oncol 9:786-795 (Pubitemid 352038317)
24. Urban M, Banks E, Egger S et al (2012) Injectable and oral contraceptive use and cancers of the breast, cervix, ovary, and endometrium in black South African women: case-control study. PLoS Med 9:e1001182
25. Ogundiran TO, Huo D, Adenipekun A et al (2010) Case-control study of body size and breast cancer risk in Nigerian women. Am J Epidemiol 172:682-690
26. Ogundiran TO, Huo D, Adenipekun A et al (2012) Body fat distribution and breast cancer risk: findings from the Nigerian breast cancer study. Cancer Causes Control 23:565-574
27. Okobia MN, Bunker CH, Zmuda JM et al (2006) Anthropometry and breast cancer risk in Nigerian women. Breast J 12:462-466 (Pubitemid 44337440)
28. Jordan I, Hebestreit A, Swai B, Krawinkel MB (2013) Dietary patterns and breast cancer risk among women in northern Tanzania: a case-control study. Eur J Nutr 52:905-915
29. Okobia MN, Bunker CH, Garte SJ et al (2008) Leptin receptor Gln223Arg polymorphism and breast cancer risk in Nigerian women: a case control study. BMC Cancer 8:338
30. Okobia MN, Bunker CH, Garte SJ et al (2009) Cytochrome P450 1B1 Val432Leu polymorphism and breast cancer risk in Nigerian women: a case control study. Infect Agent Cancer 4(Suppl 1):S12
31. Mai V, Draganov PV (2009) Recent advances and remaining gaps in our knowledge of associations between gut microbiota and human health. World J Gastroenterol 15:81-85
32. Kortenkamp A (2006) Breast cancer, oestrogens and environmental pollutants: a re-evaluation from a mixture perspective. Int J Androl 29:193-198
33. Dey S, Soliman AS, Merajver SD (2009) Xenoestrogens may be the cause of high and increasing rates of hormone receptor positive breast cancer in the world. Med Hypotheses 72:652-656
34. Etemesi BA (2007) Impact of hair relaxers in women in Nakuru, Kenya. Int J Dermatol 46(Suppl 1):23-25
35. Rosenberg L, Boggs DA, Adams-Campbell LL, Palmer JR (2007) Hair relaxers not associated with breast cancer risk: evidence from the black women's health study. Cancer Epidemiol Biomarkers Prev 16:1035-1037 (Pubitemid 46910110)
36. Wise LA, Palmer JR, Reich D, Cozier YC, Rosenberg L (2012) Hair relaxer use and risk of uterine leiomyomata in african-american women. Am J Epidemiol 175:432-440
37. Nnoruka E, Okoye O (2006) Topical steroid abuse: its use as a depigmenting agent. J Natl Med Assoc 98:934-939 (Pubitemid 43846252)
38. Olumide YM, Akinkugbe AO, Altraide D et al (2008) Complications of chronic use of skin lightening cosmetics. Int J Dermatol 47:344-353 (Pubitemid 351486476)
39. Rosenberg L, Kelly JP, Shapiro S, Hoffman M, Cooper D (2002) Risk factors for breast cancer in South African women. S Afr Med J 92:447-448 (Pubitemid 34716588)
40. Garcia-Closas M, Couch FJ, Lindstrom S et al (2013) Genomewide association studies identify four ER negative-specific breast cancer risk loci. Nat Genet 45:392
41. Michailidou K, Hall P, Gonzalez-Neira A et al (2013) Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat Genet 45:353
42. Chen F, Chen GK, Stram DO et al (2013) A genome-wide association study of breast cancer in women of African ancestry. Hum Genet 132:39-48
43. Garcia-Closas M, Brinton LA, Lissowska J et al (2006) Established breast cancer risk factors by clinically important tumour characteristics. Br J Cancer 95:123-129 (Pubitemid 43980566)
44. Yang XR, Chang-Claude J, Goode EL et al (2011) Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. J Natl Cancer Inst 103:250-263
45. Adebamowo CA, Famooto A, Ogundiran TO, Aniagwu T, Nkwodimmah C, Akang EE (2008) Immunohistochemical and molecular subtypes of breast cancer in Nigeria. Breast Cancer Res Treat 110:183-188 (Pubitemid 351793859)
46. Agboola AJ, Musa AA, Wanangwa N et al (2012) Molecular characteristics and prognostic features of breast cancer in Nigerian compared with UK women. Breast Cancer Res Treat 135:555-569
47. Awadelkarim KD, Arizzi C, Elamin EO et al (2008) Pathological, clinical and prognostic characteristics of breast cancer in Central Sudan versus Northern Italy: implications for breast cancer in Africa. Histopathology 52:445-456 (Pubitemid 351327981)
48. Bird PA, Hill AG, Houssami N (2008) Poor hormone receptor expression in East African breast cancer: evidence of a biologically different disease? Ann Surg Oncol 15:1983-1988
49. Burson AM, Soliman AS, Ngoma TA et al (2010) Clinical and epidemiologic profile of breast cancer in Tanzania. Breast Dis 31:33-41
50. Gukas ID, Jennings BA, Mandong BM et al (2005) Clinicopathological features and molecular markers of breast cancer in Jos, Nigeria. West Afr J Med 24:209-213
51. Huo D, Ikpatt F, Khramtsov A et al (2009) Population differences in breast cancer: survey in indigenous African women reveals over-representation of triple-negative breast cancer. J Clin Oncol 27:4515-4521
52. Ikpatt OF, Ndoma-Egba R (2003) Oestrogen and progesterone receptors in Nigerian breast cancer: relationship to tumour histopathology and survival of patients. Cent Afr J Med 49:122-126
53. Ly M, Antoine M, Dembele AK et al (2012) High incidence of triple-negative tumors in sub-saharan Africa: a prospective study of breast cancer characteristics and risk factors in Malian women seen in a Bamako university hospital. Oncology 83:257-263
54. Nyagol J, Nyong'o A, Byakika B et al (2006) Routine assessment of hormonal receptor and her-2/neu status underscores the need for more therapeutic targets in Kenyan women with breast cancer. Anal Quant Cytol Histol 28:97-103
55. Ohene-Yeboah M, Adjei E (2012) Breast cancer in Kumasi, Ghana. Ghana Med J 46:8-13
56. Stark A, Kleer CG, Martin I et al (2010) African ancestry and higher prevalence of triple-negative breast cancer: findings from an international study. Cancer 116:4926-4932
57. Yarney J, Vanderpuye V, Clegg Lamptey JN (2008) Hormone receptor and HER-2 expression in breast cancers among Sub-Saharan African women. Breast J 14:510-511
58. McCormack VA, Joffe M, van den Berg E et al (2013) Breast cancer receptor status and stage at diagnosis in over 1,200 consecutive public hospital patients in Soweto, South Africa: a case series. Breast Cancer Res 15:R84
59. Clegg-Lamptey JN, Dakubo JC, Attobra YN (2009) Psychosocial aspects of breast cancer treatment in Accra, Ghana. East Afr Med J 86:348-353
60. Ibrahim NA, Oludara MA (2012) Socio-demographic factors and reasons associated with delay in breast cancer presentation: a study in Nigerian women. Breast 21:416-418
61. Yarney J, Donkor A, Opoku SY et al (2013) Characteristics of users and implications for the use of complementary and alternative medicine in Ghanaian cancer patients undergoing radiotherapy and chemotherapy: a cross-sectional study. BMC Complement Altern Med 13:16
62. Adesunkanmi AR, Lawal OO, Adelusola KA, Durosimi MA (2006) The severity, outcome and challenges of breast cancer in Nigeria. Breast 15:399-409 (Pubitemid 43812214)
63. De Ver DT, Bogale S, Hobden C et al (2011) A mixed-method assessment of beliefs and practice around breast cancer in Ethiopia: implications for public health programming and cancer control. Glob Public Health 6:719-731
64. Clegg-Lamptey J, Dakubo J, Attobra YN (2009) Why do breast cancer patients report late or abscond during treatment in Ghana? A pilot study. Ghana Med J 43:127-131
65. Odigie VI, Tanaka R, Yusufu LM et al (2010) Psychosocial effects of mastectomy on married African women in Northwestern Nigeria. Psychooncology 19:893-897
66. Okobia MN, Bunker CH, Okonofua FE, Osime U (2006) Knowledge, attitude and practice of Nigerian women towards breast cancer: a cross-sectional study. World J Surg Oncol 4:11
67. Machlin A, Wakefield M, Spittal M, Hill D (2009) Cancer related beliefs and behaviours in eight geographic regions. UICC Special Report
68. Maree J, Wright S, Lu X (2013) Breast cancer risks and screening practices among women living in a resource poor community in Tshwane, South Africa. Breast J 19:453-454
69. Pillay AL (2002) Rural and urban South African women's awareness of cancers of the breast and cervix. Ethn Health 7:103-114
70. Suh MA, Atashili J, Fuh EA, Eta VA (2012) Breast self-examination and breast cancer awareness in women in developing countries: a survey of women in Buea, Cameroon. BMC Res Notes 5:627
71. Ezeome ER (2010) Delays in presentation and treatment of breast cancer in Enugu, Nigeria. Niger J Clin Pract 13:311-316
72. O'Brien KS, Soliman AS, Annan K, Lartey RN, Awuah B, Merajver SD (2012) Traditional herbalists and cancer management in Kumasi, Ghana. J Cancer Educ 27:573-579
73. Opoku SY, Benwell M, Yarney J (2012) Knowledge, attitudes, beliefs, behaviour and breast cancer screening practices in Ghana, West Africa. Pan Afr Med J 11:28
74. Kemfang Ngowa JD, Yomi J, Kasia JM, Mawamba Y, Ekortarh AC, Vlastos G (2011) Breast cancer profile in a group of patients followed up at the radiation therapy unit of the Yaounde General Hospital, Cameroon. Obstet Gynecol Int 2011:143506
75. Clegg-Lamptey J, Hodasi W (2007) A study of breast cancer in Korle Bu teaching hospital: assessing the impact of health education. Ghana Med J 41:72-77
76. Dickens C, Joffe M, Jacobson J et al (in press) Stage at breast cancer diagnosis and distance from diagnostic hospital in a periurban setting: a South African public hospital case series of over 1000 women. Int J Cancer
77. Adisa AO, Gukas ID, Lawal OO, Adesunkanmi AR (2010) Breast cancer in Nigeria: is non-adherence to chemotherapy schedules a major factor in the reported poor treatment outcome? Breast J 16:206-207
78. Galukande M, Kiguli-Malwadde E (2010) Rethinking breast cancer screening strategies in resource-limited settings. Afr Health Sci 10:89-92
79. Zelle SG, Nyarko KM, Bosu WK et al (2012) Costs, effects and cost-effectiveness of breast cancer control in Ghana. Trop Med Int Health 17:1031-1043
80. Barton MB, Frommer M, Shafiq J (2006) Role of radiotherapy in cancer control in low-income and middle-income countries. Lancet Oncol 7:584-595 (Pubitemid 43923676)
81. Abdel-Wahab M, Bourque JM, Pynda Y et al (2013) Status of radiotherapy resources in Africa: an International Atomic Energy Agency analysis. Lancet Oncol 14:e168-e175
82. Kingham TP, Alatise OI, Vanderpuye V et al (2013) Treatment of cancer in sub-Saharan Africa. Lancet Oncol 14:e158-e167
83. Olugbenga-Bello A, Oladele EA, Bello TO, Ojo JO, Oguntola AS (2011) Awareness and breast cancer risk factors: perception and screening practices among females in a tertiary institution in Southwest Nigeria. Niger Postgrad Med J 18:8-15
84. Stefan DC, Elzawawy AM, Khaled HM et al (2013) Developing cancer control plans in Africa: examples from five countries. Lancet Oncol 14:e189-e195